About the Journal

The Journal of Parkinson's Disease  (JPD) publishes original research in basic science, translational research and clinical medicine in Parkinson’s disease in cooperation with the Journal of Alzheimer's Disease. It features a first class Editorial Board and provides rigorous peer review and rapid online publication.

From 2022, the journal publishes eight issues per annual volume; prior to this it was four issues per year. From 2023 the journal will proceed as an open access publication, where all articles from the 2023 volume onwards will be openly available.

Impact Factor
JPD has a Journal Impact Factor of 5.2, and a CiteScore of 6.9 (2023 Journal Citation Reports, source: Clarivate, 2023).

Abstracted/Indexed in
Chemical Abstracts Service (CAS), Embase, Journal Citation Reports/Science Edition, MEDLINE, PsycINFO, PubsHub, Science Citation Index-Expanded (SciSearch®), Scopus


News & Social Media
View a selection of newsletters that were sent out recently by clicking on the links:
2020: Issue 1; Issue 2; Issue 3; Issue 4; Special Issue; Parkinson Prize 2020

To receive news and JAD updates, sign up via this link: http://tiny.cc/JPDsignup


Find JPD on Facebook at: facebook.com/journalpd

Follow JPD on Twitter at: twitter.com/journal_pd


The Publisher

IOS Press publishes publishes around 90 journals and 70 books annually in a broad range of subject categories, primarily specializing in biomedical and life sciences (including neurosciences, medical informatics, cancer research, rehabilitation) and physical sciences (including computer sciences, artificial intelligence, engineering).

Headquartered in Amsterdam with satellite offices in the USA, Germany and China, IOS Press continues its rapid growth, embracing new technologies for the timely dissemination of information.

All journals are available in print and electronic format.